Barney Bishop

Dr. Bishop is a professor of General Biology and Protein Biochemistry at George Mason University. Dr. Bishop received a Ph.D. in chemistry from the University of North Carolina at Chapel Hill in 1997, where his graduate research focused on peptide synthesis and engineering. After receiving his doctorate, Dr. Bishop joined the laboratory of Dr. Lynne Regan at Yale University as a postdoctoral associate in order to continue his education and gain experience in the areas of molecular biology, protein engineering and protein biophysical characterization. His research focused on reengineering helical bundle proteins in order to enhance their stability. In the spring of 2001, Dr Bishop joined New River Pharmaceuticals as a Senior Research Scientist. During his time at New River Pharmaceuticals, Dr. Bishop played a major role in the design and assembly of product lead candidates. He joined the Department of Chemistry and Biochemistry at George Mason University in the fall of 2003. His current research interests include molecular engineering, antimicrobial peptides and the design of novel therapeutic agents for combating infection, In 2007, Dr. Bishop joined the scientific advisory board for Kempharm, Inc., an early-phase biopharmaceutical company focused on the development of new and safer treatments for pain, AD/HD and other illnesses.